R. Hector MacKay-Dunn, Director at Aurinia Pharmaceuticals Inc. (AUPH), bought 5,000 shares at $11.00 ($55K) on 2022-03-09, disclosed to the SEC on 2022-03-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| AUPH | BUY | 2021-05-13 | $51K | — | Filing → |